Enhanced Capital Partners

Founded in 1999, Enhanced Capital Partners is a New York-based investment firm managing over $400 million. It specializes in equity and debt investments for small to mid-sized companies across various sectors, with a focus on healthcare technology systems and TMT industries.

Douglas Beekman

Principal

Michael K. Craven

Director

Dusty Dickerson

Managing Director

Michael A.G. Korengold

President and CEO

Mark Mauer

Senior Associate

Shane P. McCarthy

Managing Partner

Richard B. Montgomery

Managing Partner

Owen Murray

Associate

Mark R. Slusar

Managing Director, Washington D.C

Soledad Ursua

Vice President

Past deals in Compliance

SciAps

Debt Financing in 2013
SciAps, Inc. is a manufacturer of portable analytical instruments headquartered in Woburn, Massachusetts, with a facility in Laramie, Wyoming. Founded in 2012, the company specializes in developing field-hardened devices for the analysis of compounds, minerals, and elements. Its product lineup includes ReporteR, a Raman spectrometer for in-field applications; ObserveR, a handheld stand-off Raman system for detecting explosives and toxic substances; and PharmaID, a portable pharmaceutical identification tool. Additionally, SciAps offers Bench Top Spectrometers for analyzing various materials and provides reconditioned units of its Raman analyzers. The company serves diverse sectors, including food safety, pharmaceuticals, academic research, and law enforcement, through a network of salespeople and distributors. It also offers rental options for its equipment, emphasizing its commitment to providing accessible analytical solutions for various industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.